With hun­dreds of mil­lions spent on failed ac­cel­er­at­ed ap­provals, re­searchers call for faster FDA with­drawals

Be­tween 2017 and 2019, Medicare spent more than $220 mil­lion on can­cer drugs for which the in­di­ca­tions were ei­ther vol­un­tar­i­ly pulled by their ap­pli­cants or …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER